290 likes | 581 Views
Definition. Preparation of virally inactivated, SD-treated: cryoprecipitate, plasma, and cryo-poor plasma by blood establishments. Objectives. Easy-to-use, cost/effective, reliable, and affordable technologyImplementation by blood establishment with minimum infrastructure investmentIt should fit blood establishments that can prepare and test blood components following good practices .
E N D